AGP Executive Report
Last update: 7 hours agoHepatitis B Vaccine Trial: The University of Southern Denmark has approved a CDC-funded study in Guinea-Bissau that would enroll 14,000 newborns and delay the birth-dose vaccine for half of them for six weeks. The vaccine helps prevent lifelong infection, including transmission from mother to child. Guinea-Bissau’s government has not yet granted final authorization, so the trial cannot begin. Health experts have condemned the design as unethical.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.